Kabra Drugs P/B Ratio
Kabra Drugs (KABRADG) P/B ratio is 1.61 (Moderate), book value per share ₹12.50 vs Healthcare average P/B of -0.01 — Moderate - Reasonably valued relative to book value. Read Kabra Drugs dividend policy for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KABRADG P/B Ratio — Valuation Insights & Book Value Analysis
Kabra Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 1.61 (Moderate). Explore KABRADG Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
- Current PB is 43.0% below historical average
- Trading at premium to sector average PB of -0.01
Kabra Drugs P/B Ratio Historical Trend
KABRADG annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see KABRADG share price.
KABRADG Historical P/B Ratio — Book Value Per Share & Year-End Price
Kabra Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.53 | ₹12.5 | ₹19.08 | ₹30 | Moderate |
| 2025 | 2.93 | ₹10.42 | ₹30.55 | ₹25 | Moderate |
| 2024 | 4.02 | ₹2.5 | ₹10.06 | ₹1 | High |
KABRADG vs Healthcare Peers — P/B Ratio Comparison
Kabra Drugs P/B 1.61 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |